Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Diabetes Care|January 11, 2008
Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: baseline results from the ADVANCE Retinal Measurements (AdRem) studyRonald P Stolk, Mary J van Schooneveld, J Kennedy Cruickshank, et al.
Clinical Science (London, England : 1979)|January 7, 2006
Are retinal microvascular abnormalities associated with large artery endothelial dysfunction and intima-media thickness? The Hoorn StudyManon V van Hecke, Jacqueline M Dekker, Giel Nijpels, et al.
Clinical Science (London, England : 1979)|October 25, 2007
Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn StudyManon V Van Hecke, Jacqueline M Dekker, Giel Nijpels, et al.
International Journal of Epidemiology|June 9, 2016
Maelstrom Research guidelines for rigorous retrospective data harmonizationIsabel Fortier, Parminder Raina, Edwin R Van den Heuvel, et al.
The Journal of Clinical Endocrinology and Metabolism|June 11, 2010
Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndromeAli Abbasi, Eva Corpeleijn, Douwe Postmus, et al.
The Journal of Cardiovascular Nursing|February 19, 2013
Daily physical activity in stable heart failure patientsManon L Dontje, Martje H L van der Wal, Ronald P Stolk, et al.
Diabetologia|June 5, 2014
Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) studyAli Abbasi, Eva Corpeleijn, Ron T Gansevoort, et al.
Clinical Chemistry|January 8, 2017
Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND StudyAli Abbasi, Lyanne M Kieneker, Eva Corpeleijn, et al.
International Journal of Epidemiology|December 16, 2014
Cohort Profile: LifeLines, a three-generation cohort study and biobankSalome Scholtens, Nynke Smidt, Morris A Swertz, et al.
Diabetes|November 5, 2014
Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization studyAli Abbasi, Petronella E Deetman, Eva Corpeleijn, et al.
Pageof 16